Gene · 170482
Papers2,250
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,250
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Deciphering the suppressive immune microenvironment of prostate cancer based on CD4+ regulatory T cells: Implications for prognosis and therapy prediction. | Clin Transl Med | 2024 | 38239097 | PubTator, text mining | PubMed |
| Reciprocal interactions between malignant cells and macrophages enhance cancer stemness and M2 polarization in HBV-associated hepatocellular carcinoma. | Theranostics | 2024 | 38169544 | PubTator, text mining | PubMed |
| Cyclical palmitoylation regulates TLR9 signalling and systemic autoimmunity in mice. | Nat Commun | 2024 | 38169466 | PubTator, text mining | PubMed |
| Acute myeloid leukemia cutis with KMT2A::MLLT3 fusion presenting with leonine facies. | Leuk Res Rep | 2024 | 38162585 | PubTator, text mining | PubMed |
| Development of single-cell transcriptomic atlas of human plasmacytoid dendritic cells from people with HIV-1. | STAR Protoc | 2024 | 38133956 | PubTator, text mining | PubMed |
| HumanLectome, an update of UniLectin for the annotation and prediction of human lectins. | Nucleic Acids Res | 2024 | 37889052 | PubTator, text mining | PubMed |
| The development of litifilimab (BIIB 059) for cutaneous and systemic lupus erythematosus. | Immunotherapy | 2024 | 37877249 | PubTator, text mining | PubMed |
| Detection of dendritic cell subsets in the tumor microenvironment by multiplex immunohistochemistry. | Eur J Immunol | 2024 | 37840200 | PubTator, text mining | PubMed |
| An immunomodulatory antibody-drug conjugate targeting BDCA2 strongly suppresses plasmacytoid dendritic cell function and glucocorticoid responsive genes. | Rheumatology (Oxford) | 2024 | 37184875 | PubTator, text mining | PubMed |
| Tagraxofusp for blastic plasmacytoid dendritic cell neoplasm. | Haematologica | 2024 | 36951152 | PubTator, text mining | PubMed |
| Tolerogenic dendritic cells in radiation-induced lung injury. | Front Immunol | 2023 | 38259434 | PubTator, text mining | PubMed |
| Impaired activation of plasmacytoid dendritic cells via toll-like receptor 7/9 and STING is mediated by melanoma-derived immunosuppressive cytokines and metabolic drift. | Front Immunol | 2023 | 38239354 | PubTator, text mining | PubMed |
| Refined innate plasma signature after rVSVΔG-ZEBOV-GP immunization is shared among adult cohorts in Europe and North America. | Front Immunol | 2023 | 38235127 | PubTator, text mining | PubMed |
| Multiple Genomic Alterations, Including a Novel AFF4::IRF1 Fusion Gene, in a Treatment-Refractory Blastic Plasmacytoid Dendritic-Cell Neoplasm: A Case Report and Literature Review. | Int J Mol Sci | 2023 | 38203475 | PubTator, text mining | PubMed |
| 50-color phenotyping of the human immune system with in-depth assessment of T cells and dendritic cells. | bioRxiv | 2023 | 38168221 | PubTator, text mining | PubMed |
Granulocyte-Macrophage-Colony-Stimulating-Factor Combined with Prostaglandin E1 Create Dendritic Cells of Leukemic Origin from AML Patients' Whole Blood and Whole Bone Marrow That Mediate Antileukemic Processes after Mixed Lymphocyte Culture. | Int J Mol Sci | 2023 | 38139264 | PubTator, text mining | PubMed |
| Clinical, Histopathological and Molecular Spectrum of Cutaneous Lesions in Myelodysplastic Syndrome and Myeloproliferative Neoplasms (MDS/MPN): An Integrative Review. | Cancers (Basel) | 2023 | 38136431 | PubTator, text mining | PubMed |
| Blastic Plasmocytoid Dendritic Cell Neoplasm (BPDCN): Clinical Features and Histopathology with a Therapeutic Overview. | Hematol Rep | 2023 | 38132278 | PubTator, text mining | PubMed |
| Immune and oxidative stress disorder in ovulation-dysfunction women revealed by single-cell transcriptome. | Front Immunol | 2023 | 38116006 | PubTator, text mining | PubMed |
| Single-cell sequencing highlights heterogeneity and malignant progression in actinic keratosis and cutaneous squamous cell carcinoma. | Elife | 2023 | 38099574 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/170482/papers?page=5